Azioni LogicBio Therapeutics, Inc.
Azioni
LOGC
US54142F1021
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 57 | 01/04/16 |
Marie Payton
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/19 |
Matthias Hebben
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/19 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 57 | 01/04/16 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |